A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes (NCT07321886)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Obesity or Overweight, Without Type 2 Diabetes
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight who do not have type 2 diabetes. The study has two phases: a main phase and an extension phase. Participation in the main phase of the study will last about 75 weeks. Participants with prediabetes will continue in the extension phase for another 2 years.
Who can join: Review the eligibility criteria below.
Location: MFA Clinical Research — Tuscaloosa, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (162 Sites)
Showing the first 25 of 162 sites.
- MFA Clinical Research — Tuscaloosa, Alabama
- Headlands Research - Scottsdale — Scottsdale, Arizona
- Neighborhood Healthcare Institute of Health — Escondido, California
- Ark Clinical Research - Fountain Valley — Fountain Valley, California
- Desert Oasis Healthcare Medical Group — Palm Springs, California
- Peninsula Research Associates — Rolling Hills Estates, California
- Care Access - Sacramento — Sacramento, California
- Southern California Clinical Research — Santa Ana, California
- University Clinical Investigators, Inc. — Tustin, California
- Chase Medical Research, LLC — Waterbury, Connecticut
- JEM Research Institute — Atlantis, Florida
- BioMed Research & Medical Center — Miami, Florida
- Adult Medicine of Lake County, Inc. — Mt. Dora, Florida
- American Research Centers of Florida — Pembroke Pines, Florida
- AHF Pensacola — Pensacola, Florida
- IMA Clinical Research St. Petersburg — St. Petersburg, Florida
- Teak Research Consults - Dunwoody — Dunwoody, Georgia
- Teak Research Consults — Lawrenceville, Georgia
- Clinical Research Atlanta — Stockbridge, Georgia
- East-West Medical Research Institute — Honolulu, Hawaii
- Iowa Diabetes and Endocrinology Research Center — West Des Moines, Iowa
- Cotton O'Neil Clinical Research Center — Topeka, Kansas
- Care Access - Lake Charles (Bayou Pines) — Lake Charles, Louisiana
- MedStar Good Samaritan Hospital — Baltimore, Maryland
- MedStar Health Research Institute (MedStar Physician Based Research Network) — Hyattsville, Maryland
📞 Contact the Study Coordinator
Phone: (317) 615-4559
Email: LillyTrials@Lilly.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity
- Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools — Tampa, Florida
- SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity — Tucson, Arizona
- Piloting a Patient Navigator Program for Weight Loss — Philadelphia, Pennsylvania
- Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2) — Mesa, Arizona
- Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects — Orlando, Florida
- Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans — Pittsburgh, Pennsylvania
Explore by condition: All Obesity clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.